Biochemical testing to support clinical decision making is essential, but certain
The ongoing coronavirus pandemic means many patients with inflammatory bowel disease
The Quantum Blue reader analyses colorimetric tests using camera technology and
Dr. Jörg Oliver Thumfart, Labormedizinisches Zentrum Dr. Risch The Medical Laboratory
Faecal Calprotectin is a new biomarker which is helping to save money for the NHS by preventing unnecessary procedures on patients by screening out patients with IBS who do not require endoscopies.
The symptoms of functional disorders such as Irritable Bowel Syndrome (IBS) and organic inflammatory intestinal disease (IBD) can be very similar in presentation but are two very different medical conditions.
Point-of-Care Calprotectin Testing Just Got Easier with New and Improved Quantum Blue® III March 17, 2021
New App Helps Bowel Disease Patients Monitor Their Own Treatment February 24, 2021
Join Our Calprotectin Community! June 8, 2020
Calprotectin is Now Part of the New ECCO & ESGAR Guidelines August 8, 2019